MA22905A1 - Nouvelles sequences d'adn . - Google Patents

Nouvelles sequences d'adn .

Info

Publication number: MA22905A1
Authority: MA; Morocco
Prior art keywords: dna sequences; new dna; new; sequences; dna
Prior art date: 1992-06-11

Application number

MA23204A

Other languages

English (en)

Inventor

Curt Sven Magnns Enerback

Nilsson

Karl Gunnar Bjurseli

Peter Nils Ivar Carlsson

Torneli

Hansson

Liberg

Original Assignee

Astra Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-06-11

Filing date

1993-06-09

Publication date

1993-12-31

1992-06-11 Priority claimed from SE9201809A external-priority patent/SE9201809D0/xx

1992-06-12 Priority claimed from SE9201826A external-priority patent/SE9201826D0/xx

1992-07-03 Priority claimed from SE9202088A external-priority patent/SE9202088D0/xx

1993-03-19 Priority claimed from SE9300902A external-priority patent/SE9300902D0/xx

1993-06-09 Application filed by Astra Ab filed Critical Astra Ab

1993-12-31 Publication of MA22905A1 publication Critical patent/MA22905A1/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
- C12N9/20—Triglyceride splitting, e.g. by means of lipase
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/01—Animal expressing industrially exogenous proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Chemical & Material Sciences (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
Organic Chemistry (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Biochemistry (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
Environmental Sciences (AREA)
Microbiology (AREA)
Animal Husbandry (AREA)
Physics & Mathematics (AREA)
Food Science & Technology (AREA)
Animal Behavior & Ethology (AREA)
Polymers & Plastics (AREA)
Biodiversity & Conservation Biology (AREA)
Medicinal Chemistry (AREA)
Nutrition Science (AREA)
Biophysics (AREA)
Plant Pathology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Enzymes And Modification Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Saccharide Compounds (AREA)

MA23204A 1992-06-11 1993-06-09 Nouvelles sequences d'adn . MA22905A1 (fr)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
SE9201809A SE9201809D0 (sv)	1992-06-11	1992-06-11	New dna sequences
SE9201826A SE9201826D0 (sv)	1992-06-12	1992-06-12	New dna sequences ii
SE9202088A SE9202088D0 (sv)	1992-07-03	1992-07-03	New dna sequences iii
SE9300902A SE9300902D0 (sv)	1993-03-19	1993-03-19	New dna sequences iv

Publications (1)

Publication Number	Publication Date
MA22905A1 true MA22905A1 (fr)	1993-12-31

Family

ID=27484751

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA23204A MA22905A1 (fr)	1992-06-11	1993-06-09	Nouvelles sequences d'adn .

Country Status (31)

Country	Link
US (2)	US5616483A (fr)
EP (1)	EP0651793B1 (fr)
JP (1)	JP4231105B2 (fr)
KR (1)	KR100357670B1 (fr)
CN (1)	CN1071791C (fr)
AP (1)	AP411A (fr)
AT (1)	ATE447012T1 (fr)
AU (1)	AU670598B2 (fr)
CA (1)	CA2137815C (fr)
CZ (1)	CZ288677B6 (fr)
DE (1)	DE69334298D1 (fr)
DK (1)	DK0651793T3 (fr)
ES (1)	ES2335626T3 (fr)
FI (1)	FI945793L (fr)
HR (1)	HRP930935A2 (fr)
HU (1)	HU220338B (fr)
IL (1)	IL105874A (fr)
IS (1)	IS4029A (fr)
MA (1)	MA22905A1 (fr)
MX (1)	MX9303439A (fr)
NO (1)	NO944715L (fr)
NZ (1)	NZ253391A (fr)
PH (1)	PH31680A (fr)
PT (1)	PT651793E (fr)
RU (1)	RU2128708C1 (fr)
SG (1)	SG52580A1 (fr)
SI (1)	SI9300319A (fr)
SK (1)	SK286993B6 (fr)
TN (1)	TNSN93067A1 (fr)
UA (1)	UA41322C2 (fr)
WO (1)	WO1993025669A1 (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2184688A1 (fr) *	1994-03-09	1995-09-14	Pedro Antonio Prieto	Animaux transgeniques produisant des oligosaccharides et des glycoconjugues
US5907080A (en) *	1995-11-30	1999-05-25	Nexia Biotechnologies, Inc.	Method for development of transgenic dwarf goats
US7008776B1 (en) *	1996-12-06	2006-03-07	Aventis Pharmaceuticals Inc.	Compositions and methods for effecting the levels of high density lipoprotein (HDL) cholesterol and apolipoprotein AI very low density lipoprotein (VLDL) cholesterol and low density lipoprotein (LDL) cholesterol
DE69732789T2 (de) *	1996-12-06	2005-08-11	Aventis Pharmaceuticals Inc.	Von humanem lipase-ähnlichem gen kodierte polypeptide, sowie zusammensetzungen und methoden
FR2763958A1 (fr) *	1997-05-29	1998-12-04	Transgene Sa	Produit de combinaison associant un acide nucleique a une substance desorganisant la matrice extracellulaire pour la therapie genique
US20010006630A1 (en) *	1997-09-02	2001-07-05	Oron Yacoby-Zeevi	Introducing a biological material into a patient
US6699672B1 (en)	1997-09-02	2004-03-02	Insight Biopharmaceuticals Ltd.	Heparanase specific molecular probes and their use research and medical applications
US20040213789A1 (en) *	1997-09-02	2004-10-28	Oron Yacoby-Zeevi	Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodies
US6177545B1 (en) *	1997-09-02	2001-01-23	Insight Strategy & Marketing Ltd.	Heparanase specific molecular probes and their use in research and medical applications
US20020088019A1 (en) *	1997-09-02	2002-07-04	Oron Yacoby-Zeevi	Methods of and pharmaceutical compositions for improving implantation of embryos
SE9801424D0 (sv) *	1998-04-22	1998-04-22	Astra Ab	Expression methods
US20030217375A1 (en) *	1998-08-31	2003-11-20	Eyal Zcharia	Transgenic animals expressing heparanase and uses thereof
WO2000052178A1 (fr) *	1999-03-01	2000-09-08	Insight Strategy & Marketing Ltd.	Polynucleotide codant pour un polypeptide ayant une activite d'heparanase et expression de ce polynucleotide dans des cellules genetiquement modifiees
WO2000061779A1 (fr) *	1999-04-09	2000-10-19	Human Genome Sciences, Inc.	49 proteines humaines secretees
WO2001089553A1 (fr) *	1999-05-19	2001-11-29	Barnes Jewish Hospital	Coefficient d'utilisation digestive de triglycerides ameliore dans une carence en sels biliaires
CA2416732C (fr)	2000-08-02	2016-02-09	Brad St. Croix	Profils d'expression de cellules endotheliales
IT1319655B1 (it)	2000-11-15	2003-10-23	Eurand Int	Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
US20020182243A1 (en) *	2001-05-14	2002-12-05	Medo Elena Maria	Method of producing nutritional products from human milk tissue and compositions thereof
US20100268658A1 (en) *	2001-05-14	2010-10-21	Prolacta Bioscience	Method for collecting, testing and distributing milk
US6671189B2 (en) *	2001-11-09	2003-12-30	Minebea Co., Ltd.	Power converter having primary and secondary side switches
US20030213007A1 (en) *	2002-03-27	2003-11-13	Slattery Charles Wilbur	Human milk produced by human mammary tissue implanted in non-human host animals and uses thereof
WO2004108065A2 (fr) *	2003-06-09	2004-12-16	Insight Biopharmaceuticals Ltd.	Activite d'heparanase neutralisant un anticorps monoclonal anti-heparanase et d'autres anticorps anti-heparanase
WO2007035870A2 (fr) *	2005-09-20	2007-03-29	Prolacta Bioscience, Inc.	Méthode pour analyser le lait
WO2007089133A1 (fr) *	2006-02-03	2007-08-09	Academisch Medisch Centrum Bij De Universiteit Van Amsterdam	Moyens et procédés permettant d'influencer des interactions entre la dc-sign et des ligands de dc-sign
EP3248474A1 (fr) *	2006-11-29	2017-11-29	Prolacta Bioscience, Inc.	Compositions de lait humain
ES2396571T3 (es)	2006-12-08	2013-02-22	Prolacta Bioscience, Inc.	Composiciones de lípidos humanos y procedimientos de preparación y utilización de los mismos
DK2079445T3 (en)	2007-02-20	2016-02-15	Allergan Pharmaceuticals Internat Ltd	Stable digestive compositions
US10087493B2 (en)	2008-03-07	2018-10-02	Aptalis Pharma Canada Ulc	Method for detecting infectious parvovirus in pharmaceutical preparations
US8927027B2 (en)	2008-12-02	2015-01-06	Prolacta Bioscience	Human milk permeate compositions and methods of making and using same
EA029101B1 (ru)	2010-10-01	2018-02-28	Апталис Фарма Лимитид	Составы с низкой дозой панкрелипазы и кишечнорастворимым покрытием
CN103200957A (zh)	2010-10-21	2013-07-10	瑞典孤儿比奥维特鲁姆有限公司	提高人婴儿之生长速度的方法
CA2812852A1 (fr) *	2010-10-21	2012-04-26	Swedish Orphan Biovitrum Ab (Publ)	Procede pour augmenter l'absorption d'acides gras insatures par des nourrissons humains
EP2739157B1 (fr)	2011-08-03	2017-10-04	Prolacta Bioscience, Inc.	Microfiltration de lait humain pour réduire la contamination bactérienne
RU2602183C2 (ru)	2011-08-08	2016-11-10	Апталис Фарма Лтд.	Способ проведения теста на растворение твердых композиций, содержащих пищеварительные ферменты
CN103088000A (zh) *	2012-03-23	2013-05-08	北京济福霖生物技术有限公司	在哺乳动物乳腺中过表达胆盐激活脂酶的方法
SI2852668T1 (sl) *	2012-07-12	2016-09-30	Proqr Therapeutics Ii B.V.	Oligonukleotidi za izvedbo spremembe v sekvenci tarčne molekule rna, prisotne v živeči celici
EP2967094B1 (fr)	2013-03-13	2020-12-30	Prolacta Bioscience, Inc.	Produits à base de lait maternel à forte teneur lipidique
RU2679832C2 (ru)	2013-08-09	2019-02-13	Аллерган Фармасьютикалз Интернэйшнл Лимитед	Композиция пищеварительных ферментов, подходящая для энтерального введения
EP3157568A1 (fr)	2014-06-19	2017-04-26	Aptalis Pharma Limited	Procédés d'élimination de contaminants viraux dans des extraits pancréatiques
AU2016381834B2 (en)	2015-12-30	2021-09-23	Prolacta Bioscience, Inc.	Human milk products useful in pre- and post-operative care
KR20220066904A (ko)	2019-09-24	2022-05-24	프롤랙타 바이오사이언스, 인코포레이티드	염증 및 면역 질환의 치료용 조성물 및 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3256150A (en) *	1964-04-20	1966-06-14	Dairyland Food Lab	Method for treating malabsorption syndrome
GB1509866A (en) *	1975-06-10	1978-05-04	Johnson & Johnson	Enteric coated digestive enzyme compositions
US4873316A (en) *	1987-06-23	1989-10-10	Biogen, Inc.	Isolation of exogenous recombinant proteins from the milk of transgenic mammals
US5200183A (en) *	1987-11-19	1993-04-06	Oklahoma Medical Research Foundation	Recombinant bile salt activated lipases
US4944944A (en) *	1987-11-19	1990-07-31	Oklahoma Medical Research Foundation	Dietary compositions and methods using bile salt-activated lipase
SU1573026A1 (ru) *	1988-07-22	1990-06-23	Институт Биохимии И Физиологии Микроорганизмов Ан Ссср	Рекомбинантна плазмидна ДНК pBG М3, определ юща синтез эндонуклеазы рестрикции С @ BI
US5173408A (en) *	1989-11-13	1992-12-22	Lange Louis George Iii	Mammalian pancreatic cholesterol esterase
WO1991015534A1 (fr) *	1990-03-30	1991-10-17	Allied-Signal Inc.	Poly(vinylenes aromatiques) et poly (vinylenes heteoaromatiques) electroconducteurs
SE9001985D0 (sv) *	1990-06-01	1990-06-01	Astra Ab	New chemical products

1993
- 1993-05-27 US US08/068,945 patent/US5616483A/en not_active Expired - Lifetime
- 1993-05-27 HR HR930935A patent/HRP930935A2/hr not_active Application Discontinuation
- 1993-06-01 IL IL10587493A patent/IL105874A/en not_active IP Right Cessation
- 1993-06-07 IS IS4029A patent/IS4029A/is unknown
- 1993-06-09 RU RU94046360/13A patent/RU2128708C1/ru active
- 1993-06-09 UA UA94129155A patent/UA41322C2/uk unknown
- 1993-06-09 ES ES93913744T patent/ES2335626T3/es not_active Expired - Lifetime
- 1993-06-09 PT PT93913744T patent/PT651793E/pt unknown
- 1993-06-09 CA CA2137815A patent/CA2137815C/fr not_active Expired - Lifetime
- 1993-06-09 WO PCT/SE1993/000515 patent/WO1993025669A1/fr not_active Ceased
- 1993-06-09 PH PH46323A patent/PH31680A/en unknown
- 1993-06-09 SK SK1486-94A patent/SK286993B6/sk not_active IP Right Cessation
- 1993-06-09 EP EP93913744A patent/EP0651793B1/fr not_active Expired - Lifetime
- 1993-06-09 DE DE69334298T patent/DE69334298D1/de not_active Expired - Lifetime
- 1993-06-09 MA MA23204A patent/MA22905A1/fr unknown
- 1993-06-09 AU AU43667/93A patent/AU670598B2/en not_active Expired
- 1993-06-09 KR KR1019940704513A patent/KR100357670B1/ko not_active Expired - Lifetime
- 1993-06-09 FI FI945793A patent/FI945793L/fi unknown
- 1993-06-09 SG SG1996006322A patent/SG52580A1/en unknown
- 1993-06-09 AT AT93913744T patent/ATE447012T1/de active
- 1993-06-09 HU HU9403536A patent/HU220338B/hu unknown
- 1993-06-09 DK DK93913744.4T patent/DK0651793T3/da active
- 1993-06-09 CZ CZ19943091A patent/CZ288677B6/cs not_active IP Right Cessation
- 1993-06-09 NZ NZ253391A patent/NZ253391A/en not_active IP Right Cessation
- 1993-06-09 JP JP50138694A patent/JP4231105B2/ja not_active Expired - Lifetime
- 1993-06-09 MX MX9303439A patent/MX9303439A/es unknown
- 1993-06-10 AP APAP/P/1993/000538A patent/AP411A/en active
- 1993-06-11 SI SI9300319A patent/SI9300319A/sl not_active IP Right Cessation
- 1993-06-11 TN TNTNSN93067A patent/TNSN93067A1/fr unknown
- 1993-06-11 CN CN93108717A patent/CN1071791C/zh not_active Expired - Lifetime
1994
- 1994-12-07 NO NO944715A patent/NO944715L/no not_active Application Discontinuation
1995
- 1995-05-17 US US08/442,806 patent/US5716817A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
TNSN93067A1 (fr)	1994-03-17
JP4231105B2 (ja)	2009-02-25
US5616483A (en)	1997-04-01
IS4029A (is)	1993-12-12
SI9300319A (en)	1994-03-31
EP0651793B1 (fr)	2009-10-28
WO1993025669A1 (fr)	1993-12-23
UA41322C2 (uk)	2001-09-17
AU670598B2 (en)	1996-07-25
EP0651793A1 (fr)	1995-05-10
NO944715L (no)	1995-02-07
KR100357670B1 (ko)	2003-04-11
MX9303439A (es)	1994-04-29
PH31680A (en)	1999-01-18
US5716817A (en)	1998-02-10
CZ309194A3 (en)	1995-07-12
FI945793A7 (fi)	1995-02-09
CN1086262A (zh)	1994-05-04
NO944715D0 (no)	1994-12-07
RU2128708C1 (ru)	1999-04-10
HU220338B (hu)	2001-12-28
ES2335626T3 (es)	2010-03-30
HU9403536D0 (en)	1995-02-28
NZ253391A (en)	1996-01-26
IL105874A0 (en)	1993-10-20
HRP930935A2 (en)	1994-12-31
AP411A (en)	1995-09-28
DK0651793T3 (da)	2010-03-15
PT651793E (pt)	2010-01-20
RU94046360A (ru)	1997-06-10
CN1071791C (zh)	2001-09-26
AU4366793A (en)	1994-01-04
SK148694A3 (en)	1995-08-09
JPH07507687A (ja)	1995-08-31
FI945793A0 (fi)	1994-12-09
AP9300538A0 (en)	1993-07-31
HUT71789A (en)	1996-02-28
SG52580A1 (en)	1998-09-28
DE69334298D1 (de)	2009-12-10
CA2137815C (fr)	2010-11-09
CZ288677B6 (cs)	2001-08-15
FI945793L (fi)	1995-02-09
SK286993B6 (sk)	2009-09-07
IL105874A (en)	1998-12-27
CA2137815A1 (fr)	1993-12-23
ATE447012T1 (de)	2009-11-15

Publication	Publication Date	Title
MA22905A1 (fr)	1993-12-31	Nouvelles sequences d'adn .
FI924188A0 (fi)	1992-09-18	Platsspecifik spjaelkning av en enkelstraengad dna.
AR242987A1 (es)	1993-06-30	Secuencias de adn no codificada y genes quimicamente regulables.
EP1018549A4 (fr)	2002-12-18	Technique d'isolation d'adn
ATE84789T1 (de)	1993-02-15	Alpha-aryl-alpha-phenethyl-1h-1,2,4-triazol-1propan-nitrile.
DZ1835A1 (fr)	2002-02-17	Nouvelles formulations.
EP0645622A3 (fr)	1996-01-03	Analyseur des bases de l'ADN.
FI964423A7 (fi)	1996-11-04	DNA-sekvenssit
MX9205172A (es)	1993-03-01	Genes de pinosilvinsintasa.
FI883763L (fi)	1989-02-13	Frigoering av vaerdens foersvarsmediatorer i biologiska vaetskor genom systematisk behandling med dubbelstraengat rna.
DE3576524D1 (de)	1990-04-19	Dna-sequenzen.
FI923911A0 (fi)	1992-09-01	Dna-molekylers in vitro-syntes.
FI914565L (fi)	1992-03-29	Insertion av dna med modifierade transposoner.
NO932842D0 (no)	1993-08-10	1,4-benzodioksanderivater
FI931459L (fi)	1993-10-02	Sammansaettningar med 1-klor-2,2,2-trifluoretyldifluor-metyleter
DZ1781A1 (fr)	2002-02-17	Agents d'arylation.
FI915455A0 (fi)	1991-11-19	Metallurgisk ugninstallation.
FR2610625B1 (fr)	1989-06-30	2-oxo-4-(2'-difluoromethylthiophenyl)5-methoxycarbonyl-6-methyl-1,2,3,4-tetrahydropyrimidine
FR2674253B1 (fr)	1995-10-20	Composition lyophilisee pour la multiplication de sequences d'acides nucleiques.
ITTO930806A0 (it)	1993-10-28	Purificazione dell' 1,1-dicloro-1-fluoroetano.
IT8920827A0 (it)	1989-06-08	Sequenze di nucleotidi.
FR2724962B3 (fr)	1996-08-23	Tuile d'avant-toit sous-faitiere.
DE69730411D1 (de)	2004-09-30	Metastasen induzierende dna's
FR2673953B1 (fr)	1995-12-15	Procede de sequencage non radioactif d'adn.
FR2696608B1 (fr)	1994-11-04	Publiphone.